Clinical trial

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

NCT00098306

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Maraviroc (UK-427,857) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Optimized Background Therapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Optimized Background Therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-11-01

PhasePHASE2 / PHASE3

Conditions

HIV Infectionsunresolved

Interventions

Maraviroc (UK-427,857)DRUG

Optimized Background TherapyDRUG

PlaceboDRUG

Optimized Background TherapyDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

Pfizercollaborator

Mapped research locations

San FranciscoCalifornia, United States3 TampaFlorida, United States2 New YorkNew York, United States1 AtlantaGeorgia, United States1 CincinnatiOhio, United States1 PortlandOregon, United States1 MontrealQuebec, Canada1 Washington D.C.District of Columbia, United States1 AuroraColorado, United States1 AustinTexas, United States1 RochesterNew York, United States1 The BronxNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00098306 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.